Uni of Alabama at Birmingham — Birmingham, Alabama

Uni of Alabama at Birmingham is a clinical research site located in Birmingham, Alabama, United States 35249.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Uni of Alabama at Birmingham has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer.

Sponsors: Novartis Pharmaceuticals, Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Uni of Alabama at Birmingham?

Uni of Alabama at Birmingham has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Uni of Alabama at Birmingham conducted?

Uni of Alabama at Birmingham has 6 clinical trials on record, with 4 currently active. Their work covers Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, HR+/HER2- Ductal and Lobular Breast Cancer.

Is Uni of Alabama at Birmingham accredited by Crixeo Health?

Uni of Alabama at Birmingham has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Uni of Alabama at Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.